A comprehensive review of dual antiplatelet therapy (DAPT) guidelines on both sides of the Atlantic has found more common ground than disparity, likely because the US and European updates each ...

Since the development of the first bare metal (BMS) and drug-eluting stents (DES), the literature and guidelines have debated how long to continue dual antiplatelet therapy (DAPT). The most recent ...

Please provide your email address to receive an email when new articles are posted on . The American College of Cardiology and the American Heart Association have released a focused update on duration ...

Please provide your email address to receive an email when new articles are posted on . A global randomized clinical trial to evaluate 1-month dual antiplatelet therapy in patients implanted with a ...

AstraZeneca announced that Brilinta (ticagrelor) is now preferred over clopidogrel for the management of patients with acute coronary syndrome (ACS) who have received a coronary stent and in non-ST ...

The American College of Cardiology and American Heart Association (ACC/AHA) have issued new guidelines for the revascularization of coronary artery disease. The recommendations, which were drafted in ...

DUBLIN and DENVER - November 1, 2017 - Investigators today unveiled clinical data from the independently run DAPT-STEMI trial, which found no difference in patient outcomes between six-and 12-month ...

New research presented at ESC Congress today suggests that for acute coronary syndrome (ACS) patients who require percutaneous coronary intervention (PCI), treatment according to contemporary ...

Medtronic is recruiting patients for a randomized clinical trial that will investigate one-month dual-antiplatelet therapy (DAPT) in patients who have been implanted with Resolute Onyx, the company’s ...

BARCELONA, SPAIN — The European Society of Cardiology has issued a new "focused update" on its guidelines on dual antiplatelet therapy (DAPT)—aspirin plus a P2Y 12 inhibitor—in coronary artery disease ...

Medical device major Medtronic plc MDT is focusing on expanding its core Coronary and Structural Heart business. Keeping in line with this, the company recently announced a global randomized clinical ...

DAPT-STEMI Late-Breaker at TCT Reveals Results of Shortened DAPT Duration in Higher-Risk Patients DUBLIN and DENVER - November 1, 2017 - Investigators today unveiled clinical data from the ...